Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

NCT06256419 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Susceptibility, Genetic

Interventions

DRUG: GLP-1 receptor agonist
DRUG: responders group and nonresponders group

Sponsor

The Affiliated Hospital of Xuzhou Medical University